Autologous Killer Cell Therapy in Colon Cancer Patients
Condition: Colon Cancer Stage II/III Interventions: Biological: Cytokine-induced killer cell; Other: Chemotherapy AND/OR Radiation Therapy Sponsors: Sabz Biomedicals; Ministry of Health and Medical Education; Cell-based Therapies Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Iran Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Education | Iran Health | Middle East Health | Universities & Medical Training